Tag: Investigational drug

Currently, there are no specific FDA-approved medical treatments for the underlying cause of Ménière's disease, with existing therapies primarily focused on symptom management. However, the investigational drug SPI-1005, containing the compound ebselen, has shown promising results in Phase 3 clinical trials, marking a significant development in the search for a new drug for Ménière's disease.

Trodusquemine (also known as MSI-1436) is an aminosterol first isolated from the dogfish shark, *Squalus acanthias*, over two decades ago. Despite its interesting biological properties, the definitive answer to, "Can I buy trodusquemine?" is no, as it is an unapproved, experimental compound unavailable for public purchase.